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Abstract: PURPOSE This study was designed to evaluate retrospectively the long-term stent-graft pa-
tency after renovisceral revascularization with Viabahn Open Revascularization Technique (VORTEC)
using computed tomography angiography (CTA) and magnetic resonance angiography (MRA). METH-
ODS In 34 patients (seven women; mean age 72 ± 8 years) with aortic aneurysm, 63 renovisceral vessels
(i.e., 54 renal, nine visceral arteries) were revascularized with VORTEC between 2004 and 2009. All
patients obtained a pre- and postinterventional CTA and at least one follow-up CTA or MRA after 6
or more months following intervention (median follow up: 43 months). Detection of bypass occlusion,
bypass stenosis, infolding, stent-graft fractures and dislocations, and kidney shrinkage were noted by two
readers in consensus. Furthermore, mortality during follow-up was assessed using the medical report.
RESULTS During follow-up, 12.6 % of stent-grafts occluded. Cumulative patency rate was 95.2 ± 2.7 %
at 12 months, 87.7 ± 4.4 % at 24 and 36 months, and 84.7 ± 5.2 % at 48, 60, 72, 84, and 89 months,
respectively. Overall, 19 % of stent-grafts (12/63) developed bypass stenosis (<50 %, 10 stent-grafts; >
50 %, 2 stent-grafts), in one case stenosis (>70 %) was suspected to be hemodynamically significant. No
secondary dislocation, no infolding of renovisceral stent-grafts, and no stent-graft fracture occurred. Kid-
ney shrinkage occurred in nine patients, primarily in patients with an occluded Viabahn (n = 7). Eleven
patients (32.3 %) died within the follow-up time period. CONCLUSIONS In long-term survivors after
VORTEC cumulative patency rate remained high, and no stent-graft fractures or secondary dislocations
occurred.
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Abstract
Purpose This study was designed to evaluate retrospec-
tively the long-term stent-graft patency after renovisceral
revascularization with Viabahn Open Revascularization
Technique (VORTEC) using computed tomography angi-
ography (CTA) and magnetic resonance angiography
(MRA).
Methods In 34 patients (seven women; mean age
72 ± 8 years) with aortic aneurysm, 63 renovisceral ves-
sels (i.e., 54 renal, nine visceral arteries) were revascular-
ized with VORTEC between 2004 and 2009. All patients
obtained a pre- and postinterventional CTA and at least one
follow-up CTA or MRA after 6 or more months following
intervention (median follow up: 43 months). Detection of
bypass occlusion, bypass stenosis, infolding, stent-graft
fractures and dislocations, and kidney shrinkage were
noted by two readers in consensus. Furthermore, mortality
during follow-up was assessed using the medical report.
Results During follow-up, 12.6 % of stent-grafts occlu-
ded. Cumulative patency rate was 95.2 ± 2.7 % at
12 months, 87.7 ± 4.4 % at 24 and 36 months, and
84.7 ± 5.2 % at 48, 60, 72, 84, and 89 months, respec-
tively. Overall, 19 % of stent-grafts (12/63) developed
bypass stenosis (\50 %, 10 stent-grafts;[ 50 %, 2 stent-
grafts), in one case stenosis ([70 %) was suspected to be
hemodynamically significant. No secondary dislocation, no
infolding of renovisceral stent-grafts, and no stent-graft
fracture occurred. Kidney shrinkage occurred in nine
patients, primarily in patients with an occluded Viabahn
(n = 7). Eleven patients (32.3 %) died within the follow-
up time period.
Conclusions In long-term survivors after VORTEC
cumulative patency rate remained high, and no stent-graft
fractures or secondary dislocations occurred.
Keywords Computed tomography angiography 
VORTEC  Aortic aneurysm
Introduction
Treatment of thoracoabdominal aortic aneurysms (TAAA)
and pararenal aortic aneurysms (PAAA) is complex. Open
repair is considered the ‘‘gold standard’’ surgical procedure
[1, 2]; however, it involves wide aortic exposure, aortic
cross-clamping, and thus leads to intraoperative ischemia
of abdominal organs and spinal cord and poses a great risk
even for ‘‘so-called’’ fit for surgery patients [3, 4]. A hybrid
procedure, performed through an abdominal approach, is
considered less invasive than open repair and consists of
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surgical bypass to renovisceral arteries, ensuring perfusion
while preserving adequate aortic landing zones for sub-
sequent endovascular aneurysm repair [5]. Since the hybrid
operation was first introduced in 1999 [6], different studies
have shown encouraging results with acceptable mortality
rates [7–10]; however, the procedure is time consuming
and standard anastomoses to the renovisceral branches are
technically demanding and prone to bypass related com-
plications [2, 7, 11]. To simplify renovisceral debranching,
a technique using self-expanding stent-grafts, Viabahn
Open Revascularization Technique (VORTEC), has been
developed [12, 13]. The technique is characterised by
minimal dissection and a minimisation of blood flow
interruption and thus reduction of ischemia [13]. The short-
and mid-term results have shown a high patency rate of
stent-grafts [7, 14]; however, long-term patency rates have
not been documented. Thus, the purpose of this study was
to retrospectively assess stent-grafts on follow-up com-
puted tomography angiography (CTA) or magnetic reso-
nance angiography (MRA) from 6 to 89 months (median
43 months) after renovisceral revascularization with
VORTEC.
Materials and Methods
Patient Population and Study Design
Between August 2004 and March 2009, 73 patients with
TAAA or PAAA underwent renovisceral revascularisation
with VORTEC as the first step in part of the hybrid-pro-
cedure (i.e., 57 patients) or simultaneously with open graft
repair (i.e., 16 patients), when the two-step procedure was
not feasible (ruptured aneurysm, n = 6; aneurysm mor-
phologically unsuitable for endovascular repair, n = 10).
Patients with occlusive disease were not included in this
study. At our institution, the protocol for follow-up
includes CTA and clinical follow-up postinterventionally,
at 6 weeks, at 3, 6, and 12 months, and then annually. Only
patients with available pre- and postinterventional (within
1 month) CTA and at least one available follow-up CTA or
MRA after 6 months or more following the intervention
were included in this study. Twenty-five patients were lost
to follow-up within 6 months and 14 patients died; 30-day
mortality was 9.6 % (7/73).
Thus, the remaining 34 patients (27 men and 7 women,
mean age 72 ± 8 years) made up the study population. Five
patients were symptomatic, and one had a ruptured aneu-
rysm. All patients had at least one renovisceral artery re-
vascularized with the VORTEC. This technique was used in
29 patients as part of the hybrid procedure to allow endo-
vascular aneurysm repair in a second step (mean interval
between both procedures: 24 days). In five patients with
either aneurysms morphologically unsuitable for endovas-
cular repair (i.e., four patients) or ruptured aneurysm (i.e.,
one patient) open graft repair was performed simultaneously
to the visceral revascularisation (same narcosis). Patient
characteristics are displayed in Table 1. Median follow-up
was 43 (range 9–89) months. The study had institutional
review board approval, and written consent was waived.
Surgical Technique
A total of 63 renovisceral arteries (54 renal arteries and nine
visceral arteries) were revascularized using VORTEC. The
technique has already been described by our group [12, 13].
Briefly, to performVORTEC, the branch vessel is minimally
exposed and punctured, usually about a centimetre distal to
its origin; the graft device (Hemobahn/Viabahn, W.L. Gore
& Associates, Flagstaff, AZ) is introduced using the Sel-
dinger Technique.When the stent-graft is partially inside the
aortic branch and partially outside, it is expanded by balloon
dilatation. The proximal end of the stent is sutured end to side
to the main graft or deployed within a vascular graft already
connected to the vascular system. The second, more
advanced technique allows immediate restoration of blood
flow to the branch vessel and thus shorter ischemia time
(\1 min), because the proximal end to side suture to themain
graft is no longer required [13]. Finally, in most cases the
proximal end of the target artery is ligated at its origin to
prevent backflow into the aorta. For renal arteries, 5–7 mm/
5-cmViabahn aremostly used,whereas formesenteric artery
or celiac trunk 7–10 mm/5-cm Viabahn more often are
employed.
Table 1 Patient characteristics
Total number of patients 34
Disease
TAAA 14








Logistic euroscore (%) [28] 24.8 ± 15.1
ASA [29] 3.1 ± 0.3
Treatment
Hybrid (VORTEC and endovascular repair) 29
Aortic graft 5
Data are numbers or means ± standard deviations
TAAA thoracoabdominal aortic aneurysm, PAAA pararenal aortic
aneurysms, ASA American Society of Anesthesiologists
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Image Technique
CT scans were obtained with two different 64-slice CT
scanners (Somatom Definition AS/Sensation 64, Siemens
Healthcare, Germany). One hundred milliliters of nonionic
iodinated contrastmaterial (Iopromide,Ultravist 300, 300 mg
iodine/ml;Bayer Schering Pharma,Germany)was used. Tube
voltage was 100 or 120 kV, reference tube current ranged
from 110 to 210 mAs. Images were reconstructed with a slice
thickness of 2 mm, and an increment of 1.6 mm with a
medium smooth tissue convolution kernel (B30f). Dedicated
software (3mensio, The Netherlands) was used, allowing
precise measurement and characterisation of the vessels.
Before intervention, the image protocol only included an
arterial phase. Following intervention (in the first week, at
6 weeks, at 3, 6, and 12 months, and then annually), the
imaging protocol included an arterial and a venousphase scan,
and a native scan for detection of calcifications only done at
the first follow-up exam. A postinterventional CTA (within
1 month) and at least one follow-up examat 6 months ormore
after intervention (median follow-up 43 months, range
9–89 months) were available in all patients.
Two patients were followed with MRA due to renal
insufficiency. MRA were acquired on a 1.5-T MRI system
(Signa HD Echo Speed, GE Healthcare, Milwaukee, WI).
Imaging protocol included unenhanced and contrast-
enhanced sequences. A gadoterate meglumine (Dotarem,
Geurbet, Roissy, France) dose of 0.1 mmol/kg of body
weight or a gadobutrol (Gadovist, Bayer Schering Pharma,
Germany) dose of 0.1 mmol/kg body weight were used for
MRA. A coronal arterial and a venous phase were
acquired, each within a single breath hold.
Postprocessing technique included multiplanar refor-
mation (MPR), curved MPR, and volume rendering (VR).
MPR is a technique that enables the viewer to generate
cross-sections in any plane. A curved plane provides a
curved MPR, useful for more accurate assessment of tor-
tuous vessels [15]. VR is commonly used to generate a
volumetric display by rendering the entire volume of data
and is especially useful for better illustration of complex
vascular anatomy (Fig. 1).
Image assessment
Two radiologists retrospectively assessed pre- and postinter-
ventional image examinations in consensus. On the preinter-
ventional CTA, kidney size was assessed. On postinterventional
image studies bypass occlusion (defined as complete occlusion),
bypass stenosis (endoluminal narrowing) (graded as follow-
ing;\50 %, 50–70 %, and[70 %), stent-graft dislocations,
infolding, stent-graft fractures, and kidney size was assessed.
Kidney shrinkage was defined as a change in size of more than
1 cmandan interpole distanceof less than the10 %percentile of
normal value, according to gender and side (10 % percentile of
normal kidney length, men, right side, 99.0 mm; men, left side,
100.0 mm; women, right side, 90.31 mm; women, left side,
92.12 mm) [16].
Mortality
Mortality of patients during follow-up was assessed using
the medical report (KISIM, clinic information system,
Cistec AG, Switzerland). Thirty-day mortality was not
assessed, because we only included patients with at least
one follow-up image after 6 months or more.
Statistical Analysis
Statistical analysis was performed using SPSS (SPSS,
release 18.0 for Windows; SPSS, Chicago, IL). Results for
continuous variables were reported as mean ± standard
deviation (SD). Cumulative stent-graft patency rate was
estimated by using Kaplan–Meier life table analysis.
Results
Bypass Occlusion
Cumulative patency rate (i.e., stent-grafts with no occlu-
sion) was 95.2 ± 2.7 % at 12 months, 87.7 ± 4.4 % at 24
Fig. 1 Volume rendering (VR) of a 77-year-old male patient after
revascularization of both renal arteries with Viabahn Open Revascu-
larization Technique (VORTEC) and open graft repair following
PAAA. The right renal stent-graft (6-mm Viabahn) has been
implanted into the superior mesenteric artery and the left renal
stent-graft (6-mm Viabahn) into the aortic graft
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and 36 months, and 84.7 ± 5.2 % at 48, 60, 72, 84, and
89 months (Fig. 2). Of the detected stent-graft occlusions
(i.e., 8/63), all were to the renal arteries (unilateral, six
patients; bilateral, one patient; Fig. 3). Three stent-graft
occlusions were without detectable cause, and one patient
showed kinking of the stent-graft. These patients did not
receive an intervention following stent-graft occlusion.
Three patients developed renal stent-graft occlusion in a
context of probable graft infection associated with aorto-
enteric fistula. Two of these patients showed unilateral
thrombosis (at 9 months; at 41 months), whereas one
showed bilateral thrombosis of renal Viabahn (at
19 months), as well as thrombosis of feeding-graft to the
superior mesenteric artery (subsequent thrombus aspiration
was successful). Nevertheless, the patient died periopera-
tively due to mesenterial ischemia. The former two patients
with graft infection required emergency intervention (par-
tial duodenal resection and repair of aortic graft; thrombin
injection of a secondary pseudoaneurysm associated with
aortoduodenal fistula), both died following intervention.
After 48 months, no additional stent-graft occlusion was
observed.
Bypass Stenosis
Overall, 19 % of stent-grafts (i.e., 12/63) developed bypass
stenosis during follow-up (\50 %, 10 stent-grafts;
50–70 %, 1 stent-graft;[70 %, 1 stent-graft; Fig. 4). Two
patients developed stenosis (both\50 %) in stent-grafts to
the superior mesenteric artery and to the coeliac trunk
within 1 month, which resolved spontaneously. Within
12 months, one visceral stent-graft and one renal stent-
graft showed stenosis (visceral stent-graft,\50 %; renal
stent-graft,\50 %); the renal stenosis resolved spontane-
ously. These ‘‘vanishing stenosis’’ most likely represented
mural thrombi that spontaneously lyse. Within 24 months,
three more renal stent-grafts showed stenosis (all\50 %),
one showed increasing stenosis within 1 year more
(50–70 %), and total occlusion at 41 months. Within
36 months, three more renal stent-grafts developed stenosis
(1 stent-graft,[70 %; 2 stent-grafts,\50 %). In the more
severe case, balloon dilatation and stenting were
Fig. 2 Graph showing cumulative primary patency rate of stent-
grafts over the time of follow-up (upto 89 months). Vessels at risk:
baseline, 63; 12 months, 57; 24 months, 44; 36 months, 36;
48 months, 24; 60 months, 15; 72 months, 6; 84 months, 1
Fig. 3 A Transverse image reconstruction of a 75-year-old male
patient shows occlusion of stent-graft to the left renal artery.
B Corresponding curved MPR confirming total occlusion
Fig. 4 A Transverse image reconstruction of 83-year old male
patient shows eccentric in-stent stenosis (\50 %) of the stent-graft to
the right renal artery. B Corresponding curved MPR
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successful. The patient died 5 months later of unknown
cause. Renal bypass stenosis was noted in another patient
within 48 months (\50 %) and within 96 months (\50 %),
respectively.
Stent-graft Dislocation, Infolding of Stent-graft,
and Fracture
No stent-graft used for renovisceral revascularization
showed dislocation or infolding. Furthermore, no stent-
graft fracture was observed.
Kidney Shrinkage
Nine patients (i.e., 26.5 %) showed kidney shrinkage
(unilateral, 8 patients; bilateral, 1 patient). Seven cases
were due to occlusion of renal VORTEC: one after
encroachment of a renal branch. One patient showed kid-
ney shrinkage due to occlusion of a renal artery that was
not revascularised by VORTEC. Another case was due to
occlusion of a renal bypass following redo EVAR and
secondary renal bypass after proximal neck aneurysm
(2 months after open graft repair and revascularisation of
renal artery on the other side).
Mortality
Of the 34 patients included in this study, 11 (i.e., 32.3 %)
died during the follow-up period. Three patients died fol-
lowing graft infection and associated aortoenteric fistula (at
9 months; at 19 months; at 41 months), and two patients
died following gastrointestinal bleeding (at 12 months; at
34 months). One patient died due to bowel ischemia,
without occlusion of renovisceral stent-grafts (at
15 months). One patient died from pneumonia in the
context of bronchial carcinoma (at 26 months) and one
from respiratory insufficiency (at 31 months). Three
patients died of unknown cause.
Discussion
Despite the improvement of surgical techniques and strat-
egies, revascularization of renovisceral vessels using con-
ventional suture remains challenging, time-consuming, and
prone to complications. Especially in high-risk patients
with increasing age and comorbidities, organ ischemia and
time-consuming procedures can lead to major postopera-
tive complications [2, 11]. In this context, a sutureless and
clampless anastomosis technique based on the use of the
Viabahn has been recently developed to simplify renovis-
ceral debranching and to reduce end-organ ischemia time
[13]. First studies have shown promising short- and mid-
term results [7, 14, 17]; however, there are no reports about
long-term outcome of stent-grafts used for this indication.
Our study retrospectively evaluated the long-term outcome
of the Viabahn used for VORTEC in a cohort of 34 patients
based on CTA and MRA, with a follow-up of up to
89 months.
Recent studies [7, 12–14, 17] showed good short- and
mid-term patency rates. In this study, we demonstrated that
stent-graft patency rates remained high over a median
follow-up of 43 months (at 89 months 84.7 ± 5.2 %),
which supports the viability of this novel surgical
approach. Furthermore, after 48 months no additional
stent-graft occlusion was observed. Endoluminal narrowing
was seen in 19 % of stent-grafts; only one showed steno-
sis[70 %. VORTEC has been used mostly in renovisceral
vessels considered hostile for standard suturing technique.
A majority of targeted vessels showed diffuse disease and
were of small diameter. In such vessels, flow profiles might
have a high-risk for thrombosis and stenosis. Furthermore,
it is worthwhile to mention that in these very first VOR-
TEC cases the older generation Viabahn with no heparin
coating was used. Recently, only the Viabahn with a stable
and long-time acting Carmeda coating has been used. In
addition, optimal platelet inhibition and anticoagulation
regimens for both acute and long-term applications have
not been defined for renovisceral surgery or in the case
where VORTEC is used.
Secondary stent-graft dislocation has been another
concern; however, in this study there was no renovisceral
stent-graft migration and no stent-graft fracture. Thus, the
use of this technique may be extended, and recent studies
have shown excellent results employing VORTEC to the
supra-aortic vessels [17, 18] as well as to the above-knee
femoropopliteal anastomosis [19, 20].
Alternative treatment options for aortic aneurysm
include fenestrated and chimney endografts or open aneu-
rysm repair. Recent studies have shown 1-year survival
rates of 57–89.1 % for patients treated with chimney
technique and of 85–93 % for patients treated with fenes-
trated endografts, and 5-year survival rates of 60 % for
patients treated with fenestrated endografts [21–23]. For
elective open aneurysm repair, reported survival rates at
1 year are 73–89 % and at 5–6 years 69.9–84.5 % [2, 24–
26]. In our study, we only included patients who had fol-
low-up imaging after 6 months or more; however, in a
previous study our group assessed mortality rate in patients
electively treated with VORTEC as part of the hybrid
procedure, which has shown to be 8.6 % in 30 days and
25.8 % during a mean follow-up of 22.1 months. [7].
Recent studies also have shown excellent results expanding
the use of VORTEC, employing VORTEC to the supra-
aortic vessels [17, 18], as well as to the above-knee fem-
oropopliteal anastomosis [19, 20].
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The main limitation of our study is that we only assessed
Viabahn in patients with at least one imaging follow-up
after 6 months or more, and therefore stent-graft compli-
cations in patients who did not survive the first 6 months or
were lost to follow-up were not taken into account. We
refer to another publication that already addressed this
topic [7]. Furthermore, this was a retrospective study with
only a limited number of high-risk patients, and the patient
group was heterogeneous with respect to risk factors and
treatment.
Concerning assessment of the kidneys, we only analysed
the change in size and not focal infarction or renal function.
Thus, change in size due to other factors, such as chronic
kidney diseases, cannot be excluded.
Conclusions
The use of VORTEC in patients with TAAA or PAAA
might be an effective way to maintain blood flow to the
renovisceral arteries. CTA- and MRA-based results show
good long-term patency of stent-grafts from 6 to 89 months
and no stent-graft migration or fraction. However, endo-
luminal narrowing can be observed in almost 20 % of
stent-grafts, and close surveillance is required.
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